Eph/ephrin Signaling as a Potential Therapeutic Target After Central Nervous System Injury

E-ISSN： 1873-4286|13|24|2507-2518

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.24, 2007-08, pp. : 2507-2518

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) Inhibitors

Current Drug Targets, Vol. 16, Iss. 10, 2015-09 ,pp. : 1048-1056

Bentham Science Publishers

Access to resources Recommend Favorite

The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 2, 2009-06 ,pp. : 95-109

Bentham Science Publishers

Access to resources Recommend Favorite

ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 3, 2006-09 ,pp. : 193-210

Bentham Science Publishers

Access to resources Recommend Favorite

Trigonelline: A Plant Alkaloid with Therapeutic Potential for Diabetes and Central Nervous System Disease

Current Medicinal Chemistry, Vol. 19, Iss. 21, 2012-07 ,pp. : 3523-3531

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of anti-cytokine strategies in central nervous system ischaemia

By Clark W.M. Lutsep H.L.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 407-415

Informa Healthcare

Access to resources Recommend Favorite